Tag: Psoriasis
Ustekinumab More Effective Than TNF-α Inhibitors in Psoriasis
Ustekinumab more effective than three tumor necrosis factor-α-inhibitors at six, 12 months
Abdominal Aortic Aneurysm Odds Up for Patients With Psoriasis
Those with severe psoriasis 67 percent more likely to develop an AAA
Incidence of Psoriatic Arthritis 2.7/100 Psoriasis Patients
Variables linked to PsA development include severe psoriasis, low level of education, retinoid use
FDA Approves Inflectra as ‘Biosimilar’ to Remicade
For adults with Crohn's, rheumatoid arthritis, or psoriasis
Psoriasis Does Not Worsen Total Hip Arthroplasty Outcomes
WOMAC OA Index scores for pain or function did not differ for patients with psoriasis, osteoarthritis
Anti-TNF Treatment Ups ANA Positivity in Psoriasis
Increased antinuclear antibody positivity, but no change in PASI-75 response rates
More Severe Psoriasis Equals More Vascular Inflammation
Relationship held after accounting for other cardiovascular disease risk factors
Two Experimental Drugs Promising for Psoriasis Rx
Targeted therapies produce significant results, researchers say
More Evidence Psoriasis and Depression Are Linked
But research doesn't prove one causes the other
Study Looks at Costs for Moderate to Severe Plaque Psoriasis
Most patients prescribed one or more medications; six-month total direct costs per patient $11,291
